Skip to main content

Table 3 Percent change of lipid parameters in each treatment group at the end of the first phase

From: Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study

Lipid parameters

Pravastatin (n = 11)

Phytosterols (n = 8)

Combination (n = 15)

p value

Mean

SD

Mean

SD

Mean

SD

TC

−17.79

5.44

−4.16

7.60

−17.70

12.64

0.006*

TG

−16.33

29.82

−4.08

23.98

−0.52

42.09

0.516

HDL-c

5.27

8.47

−0.07

14.07

−2.31

12.97

0.290

LDL-c

−28.76

9.32

−9.12

7.84

−27.08

15.68

0.003*

  1. * Significantly different between either pravastatin or combination compared to phytosterols group (p = 0.002).